These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36983437)

  • 1. Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study.
    Osmanodja B; Akifova A; Oellerich M; Beck J; Bornemann-Kolatzki K; Schütz E; Budde K
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
    J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study.
    Oellerich M; Shipkova M; Asendorf T; Walson PD; Schauerte V; Mettenmeyer N; Kabakchiev M; Hasche G; Gröne HJ; Friede T; Wieland E; Schwenger V; Schütz E; Beck J
    Am J Transplant; 2019 Nov; 19(11):3087-3099. PubMed ID: 31062511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection.
    Steggerda JA; Pizzo H; Garrison J; Zhang X; Haas M; Kim IK; Jordan SC; Puliyanda DP
    Pediatr Transplant; 2022 Jun; 26(4):e14258. PubMed ID: 35340104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: A single center study.
    Ranch D; Fei M; Kincade E; Piburn K; Hitchman K; Klein K
    Pediatr Transplant; 2024 Feb; 28(1):e14582. PubMed ID: 37550268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation.
    Obrișcă B; Butiu M; Sibulesky L; Bakthavatsalam R; Smith KD; Gimferrer I; Warner P; Ismail G; Leca N
    Sci Rep; 2022 Sep; 12(1):15061. PubMed ID: 36064740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Response of Donor-Derived Cell-Free DNA Following Treatment of Acute Rejection in Kidney Allografts.
    Wolf-Doty TK; Mannon RB; Poggio ED; Hinojosa RJ; Hiller D; Bromberg JS; Brennan DC
    Kidney360; 2021 Apr; 2(4):729-736. PubMed ID: 35373051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury.
    Stites E; Kumar D; Olaitan O; John Swanson S; Leca N; Weir M; Bromberg J; Melancon J; Agha I; Fattah H; Alhamad T; Qazi Y; Wiseman A; Gupta G
    Am J Transplant; 2020 Sep; 20(9):2491-2498. PubMed ID: 32056331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition of Renal Patients Using AlloSure Into Community Kidney Care (TRACK): Protocol for Long-Term Allograft Surveillance in Renal Transplant Recipients.
    Dale BL; Bose S; Kuo S; Burns A; Daou P; Short J; Miles J
    JMIR Res Protoc; 2021 Mar; 10(3):e25941. PubMed ID: 33720033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation.
    Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B
    J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
    Mayer KA; Doberer K; Tillgren A; Viard T; Haindl S; Krivanec S; Reindl-Schwaighofer R; Eder M; Eskandary F; Casas S; Wahrmann M; Regele H; Böhmig GA
    Transpl Int; 2021 Sep; 34(9):1689-1702. PubMed ID: 34448270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation.
    Mantios E; Filiopoulos V; Constantoulakis P; Liapis G; Vittoraki A; Casas S; Marinaki S; Boletis JN
    Transpl Int; 2023; 36():11507. PubMed ID: 37901296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial.
    Benning L; Morath C; Fink A; Rudek M; Speer C; Kälble F; Nusshag C; Beimler J; Schwab C; Waldherr R; Zeier M; Süsal C; Tran TH
    Transpl Int; 2023; 36():11899. PubMed ID: 38020751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study.
    Bu L; Gupta G; Pai A; Anand S; Stites E; Moinuddin I; Bowers V; Jain P; Axelrod DA; Weir MR; Wolf-Doty TK; Zeng J; Tian W; Qu K; Woodward R; Dholakia S; De Golovine A; Bromberg JS; Murad H; Alhamad T
    Kidney Int; 2022 Apr; 101(4):793-803. PubMed ID: 34953773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated fractional donor-derived cell-free DNA during subclinical graft injury after liver transplantation.
    Baumann AK; Beck J; Kirchner T; Hartleben B; Schütz E; Oellerich M; Wedemeyer H; Jaeckel E; Taubert R
    Liver Transpl; 2022 Dec; 28(12):1911-1919. PubMed ID: 35429207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Molecular Processes Mediate Donor-derived Cell-free DNA Release From Kidney Transplants in Different Disease States.
    Gauthier PT; Madill-Thomsen KS; Demko Z; Prewett A; Gauthier P; Halloran PF;
    Transplantation; 2024 Apr; 108(4):898-910. PubMed ID: 38150492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-Derived Cell-Free DNA as a Non-Invasive Biomarker for Graft Rejection in Kidney Transplant Recipients: A Prospective Study among the Indian Population.
    Kumar N; Tandon A; Rana R; Rana DS; Bhalla AK; Gupta A; Sachdeva MP; Huirem RS; Chauhan K; Yashavarddhan MH; Basnal A; Gupta R; Mallick PK; Ganguly NK
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care.
    Keller M; Sun J; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
    J Heart Lung Transplant; 2022 Apr; 41(4):458-466. PubMed ID: 35063338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-Free DNA and Active Rejection in Kidney Allografts.
    Bloom RD; Bromberg JS; Poggio ED; Bunnapradist S; Langone AJ; Sood P; Matas AJ; Mehta S; Mannon RB; Sharfuddin A; Fischbach B; Narayanan M; Jordan SC; Cohen D; Weir MR; Hiller D; Prasad P; Woodward RN; Grskovic M; Sninsky JJ; Yee JP; Brennan DC;
    J Am Soc Nephrol; 2017 Jul; 28(7):2221-2232. PubMed ID: 28280140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.